Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd Live Price Chart
Performance
| Previous Close | ₹ 24.99 |
| High | ₹ 25.35 |
| Volume | 2484 |
| 52W Range | ₹ 18.42 - ₹ 42.75 |
| Open | ₹ 25.35 |
| Low | ₹ 23.11 |
| Market Cap | ₹ 12.23 Cr |
Emmessar Biotech & Nutrition Ltd Technicals
| 20 Day | ₹ 24.254 |
| 50 Day | ₹ 24.640 |
| 100 Day | ₹ 25.217 |
| 200 Day | ₹ 26.819 |
| 20 Day | ₹ 24.279 |
| 50 Day | ₹ 24.677 |
| 100 Day | ₹ 25.275 |
| 200 Day | ₹ 26.592 |
Emmessar Biotech & Nutrition Ltd Fundamentals
| ROCE | 6.692 |
| P/E Ratio | 29.800 |
| P/B Ratio | 1.450 |
| Industry P/E | 1.450 |
| Debt to Equity | 40.994 |
| ROE | 5.372 |
| EPS | 0.790 |
| Dividend Yield | 0.000 |
| Book Value | 16.240 |
| Face Value | 10.000 |
Emmessar Biotech & Nutrition Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 2.6196 | 2.5473 | 2.7699 | 2.2837 | 8.4564123 |
| Total Expenses | 1.6614 | 1.7347 | 1.803 | 1.3522 | 6.2018797 |
| Profit After Tax | 0.3162 | 0.7496 | 0.5038 | 0.4754 | 1.4497427 |
Emmessar Biotech & Nutrition Ltd Shareholding Pattern
| Promoter Holdings | 59.529 % |
| FIIs | 0.000 % |
| DIIs | 0.144 % |
| MutualFund | 0.052 % |
| Retail | 38.067 % |
| Others - | 2.208 % |
About Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The Company has so far, succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996. To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated. ECIL's research team established that the specialty chemicals made by them had potential as 'Vital Micro Nutrients', used worldwide in research as 'tools' of Biotechnology. The Company's management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturer's and consumer's minds. EBNL's R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well estab ...
Similar Stocks
| Advance Petrochemicals Ltd Chemicals | ₹ 308.30 +14.65 (+4.99%) |
| Atul Ltd Chemicals | ₹ 6,386.00 -69.35 (-1.07%) |
| BASF India Ltd Chemicals | ₹ 3,781.00 -67 (-1.74%) |
| Oriental Aromatics Ltd Chemicals | ₹ 467.00 -21.25 (-4.35%) |
| Citurgia Biochemicals Ltd Chemicals | ₹ 107.60 -1.05 (-0.97%) |
| DIC India Ltd Chemicals | ₹ 575.00 -22.25 (-3.73%) |
FAQs on Emmessar Biotech & Nutrition Ltd
1. Can I buy Emmessar Biotech & Nutrition Ltd from PL Capital? ›
2. Does Emmessar Biotech & Nutrition Ltd pay dividends? ›
3. What is the current share price of Emmessar Biotech & Nutrition Ltd ? ›
4. What is the 52-week high and low of Emmessar Biotech & Nutrition Ltd ? ›
Start SIP in Emmessar Biotech & Nutrition Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
